Search - tctmd.com

Displaying 101 - 120 of 427

Sort: Relevancy | Date

News Daily News

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Caitlin E. Cox

August 04, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

L.A. McKeown

June 21, 2022

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Daily News

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

Caitlin E. Cox

May 10, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Conference News HRS 2022

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

Todd Neale

May 02, 2022

News Conference News ACC 2022

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

L.A. McKeown

April 08, 2022

News Conference News ACC 2022

METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF

Todd Neale

April 08, 2022

News Conference News ACC 2022

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

Todd Neale

April 06, 2022

News Conference News ACC 2022

PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization

L.A. McKeown

April 03, 2022

News Conference News ACC 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Michael O'Riordan

April 02, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Daily News

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Caitlin E. Cox

March 31, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2022

Shelley Wood

February 28, 2022

News Daily News

Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA

Yael L. Maxwell

January 27, 2022

Advertisement

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Guideline-Directed Therapies Underused in Frail HF Patients

TCTMD’s Top 10 Most Popular Stories for February 2022

Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content